Navigation Links
VaxGen Reports Financial Update
Date:3/6/2008

SOUTH SAN FRANCISCO, Calif., March 6 /PRNewswire-FirstCall/ -- VaxGen Inc. (Pink Sheets: VXGN), a biopharmaceutical company, today reported its year end financial results and more recent cash balance, with a view to ensuring that stockholders have the most current financial information ahead of voting on the company's proposed merger with Raven biotechnologies inc. VaxGen's Board of Directors has set March 28, 2008 as the date for the Special Meeting of Stockholders to vote on the proposed merger.
(Logo: http://www.newscom.com/cgi-bin/prnh/19991112/VAXGENLOGO )

Specifically, VaxGen announced the following:

-- Cash, cash equivalents and investment securities at December 31, 2007

totaled $71.6 million, or $40.1 million net of the $31.5 million face

amount of convertible debt outstanding at that time.

-- Cash, cash equivalents and investment securities at the most recent

month end of February 29, 2008 totaled $64.9 million. Net of

outstanding convertible debt on that date at face amount, the February

month end balance was $34.9 million.

-- The company recorded a non-cash asset impairment charge of $10.7

million in its 2007 financial statements, which included a reduction in

the book value of its manufacturing facility from $16.2 million to

$10.0 million. This reduction reflects management's current best

estimate of fair market value. VaxGen has not yet received an offer

for the manufacturing facility and there can be no guarantee that the

company will succeed in entering into a transaction at this reduced

value, or indeed at all. VaxGen expects to file its 2007 financial

statements with the Securities and Exchange Commission on Form 10-K on

or before March 17, 2008.

"VaxGen's management and Board are looking
'/>"/>

SOURCE VaxGen Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology technology :

1. VaxGen to Present at the 10th Annual BIO CEO and Investor Conference
2. VaxGen and Raven Announce Form S4 Registration Statement Declared Effective
3. VaxGen Stockholders Overwhelmingly Approve Reverse Split Proposal
4. VaxGen Common Stock Expected to Qualify for Quotation on OTC Bulletin Board
5. VaxGen Addresses MPM Claims in Letter to Stockholders
6. VaxGen Files Last Outstanding Periodic Report With SEC
7. Jack Anthony to Resign From VaxGens Board After Accepting CEO Position at Osprey Pharmaceuticals
8. VaxGen Files First Quarter 2007 Financials
9. VaxGen Further Restructures to Preserve Cash as It Pursues Strategic Initiatives
10. VaxGen Files 2006 Financial Statements and Provides Cash Update
11. EntreMed Reports Fourth Quarter and Year-End 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... , Jan. 22. 2015  Varian Medical Systems (NYSE: ... been honored for its commitment to sustainability with inclusion on ... is the highest ranked healthcare equipment company among the Corporate ... the World Economic Forum at Davos, Switzerland ...
(Date:12/24/2014)... Dec. 24, 2014  United Therapeutics Corporation (NASDAQ: ... MDT ) has submitted a pre-market approval application ... the use of Medtronic,s SynchroMed ® II implantable ... use with United Therapeutics, Remodulin ® (treprostinil) Injection ...
(Date:12/24/2014)... “Preparative & Process Chromatography Market by Instrument (Liquid ... Valves, Guages, Seals), Accessories, Services, End User (Biotechnology, ... provides a detailed overview of the major drivers, ... impacting the preparative and process chromatography market along ...
(Date:12/24/2014)... MD (PRWEB) December 23, 2014 On ... H.R. 83, the Omnibus and Continuing Resolution Appropriations Act ... a condition eligible to receive funding through the Congressionally ... of Defense (DoD). The Hydrocephalus Association (HA), working in ...
Breaking Biology Technology:Varian Honored Among World's 100 Most Sustainable Corporations 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 2United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 3United Therapeutics Announces Submission Of Pre-Market Approval Application For Implantable Drug Infusion System To Deliver Remodulin 4Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4Rare Brain Condition Now Eligible for Department of Defense Research Dollars 2
... been granted a new patent on its technology for using ... cells. Platypus is a nanotechnology company with 21 employees that ... , , View the patent , , Previous ... board of directors , , Platypus Technologies receives ...
... Ever since the Trojans hauled that giant wooden statue ... of armed Greeks in the streets, people have been ... that careful policy - within reason. , ,The state ... it considers a landmark plan to build the first ...
... — Third Wave Technologies, Inc. has ... an attorney that helped litigate Third Wave's successful patent ... announced that it would host a conference call on ... first quarter earnings. , ,Third Wave, which develops and ...
Cached Biology Technology:Seven good reasons to approve the Institutes for Discovery 2Seven good reasons to approve the Institutes for Discovery 3Third Wave announces two senior management appointments 2
(Date:1/22/2015)... Issued by Small Cap IR. In 2011, Nilson Report,s annual ... merchants on the leading payment cards rose to $135.3 billion ... prepaid cards reached 6.54 billion.  Eight million credit card users ... 2012, and credit and debit card fraud resulted in $11.27 ...
(Date:1/22/2015)... Jan. 22, 2015   EyeLock, Inc. , a market leader ... Steve Gerber to the new role of Senior ... for leading development of mobile platforms and wearable solutions for ... and innovation in the semiconductor industry to his role at ...
(Date:12/22/2014)... Dec. 22, 2014  NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market, announces it has ... for the 2015 International CES debut of the Wocket™ ... will be at the NXT-ID booth January 6th and 7 ...
Breaking Biology News(10 mins):$4.80 Near Term Price Target with "Buy" given by CapRock Research for NXT-ID, Inc. (NASDAQ: NXTD) issued by Small Cap IR 2EyeLock Names Steve Gerber as Senior Vice President of Mobile and Wearables 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 2NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 3NXT-ID Hires Master Pickpocket and Security Consultant Apollo Robbins for Wocket Smart Wallet CES 2015 Debut 4
... the University of Illinois at Urbana-Champaign have demonstrated for ... used to trap, manipulate, and probe nanoparticles, including fragile ... plasmonic nanoantennas enhance local fields by up to several ... can use these structures with a regular CW laser ...
... discovery of a new gene could lead to better ... and appearing on the cover of this week,s ... that domestic tomatoes could re-learn a thing or two ... to tomato crops losing beneficial traits common to wild ...
... papers posted online from 20 July through 14 ... Turkey, Nova Scotia, Switzerland, New Mexico, and the U.S. ... age dating using zircon crystals, the Code of Stratigraphic ... GSA Bulletin articles published ahead of print are ...
Cached Biology News:Newly demonstrated capabilities of low-powered nanotweezers may benefit cellular-level studies 2New gene could lead to better bug-resistant plants 2Summer Geoscience from GSA Bulletin 2Summer Geoscience from GSA Bulletin 3Summer Geoscience from GSA Bulletin 4Summer Geoscience from GSA Bulletin 5Summer Geoscience from GSA Bulletin 6Summer Geoscience from GSA Bulletin 7Summer Geoscience from GSA Bulletin 8Summer Geoscience from GSA Bulletin 9Summer Geoscience from GSA Bulletin 10Summer Geoscience from GSA Bulletin 11Summer Geoscience from GSA Bulletin 12Summer Geoscience from GSA Bulletin 13Summer Geoscience from GSA Bulletin 14Summer Geoscience from GSA Bulletin 15
Includes USB cable, custom driver and one roll of thermal paper...
Newborn Bovine Serum Heat-Inactivated...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Edited by I.H. Pawlowitzki, J.H. Edwards and E.A. Thompson (1997) • This volume covers: Linkage in dominant recessive and oligogenic disease, Model free (non-parametric) methods, Tools for gene ...
Biology Products: